Development of a real-time imaging system for hypoxic cell apoptosis

Go Kagiya, Ryohei Ogawa, Fuminori Hyodo, Kei Yamashita, Mizuki Nakamura, Ayumi Ishii, Yukihiko Sejimo, Shintaro Tominaga, Masaharu Murata, Yoshikazu Tanaka, Masanori Hatashita

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    Hypoxic regions within the tumor form due to imbalances between cell proliferation and angiogenesis; specifically, temporary closure or a reduced flow due to abnormal vasculature. They create environments where cancer cells acquire resistance to therapies. Therefore, the development of therapeutic approaches targeting the hypoxic cells is one of the most crucial challenges for cancer regression. Screening potential candidates for effective diagnostic modalities even under a hypoxic environment would be an important first step. In this study, we describe the development of a real-time imaging system to monitor hypoxic cell apoptosis for such screening. The imaging system is composed of a cyclic luciferase (luc) gene under the control of an improved hypoxic-responsive promoter. The cyclic luc gene product works as a caspase-3 (cas-3) monitor as it gains luc activity in response to cas-3 activation. The promoter composed of six hypoxic responsible elements and the CMV IE1 core promoter drives the effective expression of the cyclic luc gene in hypoxic conditions, enhancing hypoxic cell apoptosis visualization. We also confirmed real-time imaging of hypoxic cell apoptosis in the spheroid, which shares properties with the tumor. Thus, this constructed system could be a powerful tool for the development of effective anticancer diagnostic modalities.

    Original languageEnglish
    Number of pages1
    JournalMolecular Therapy - Methods and Clinical Development
    Volume3
    DOIs
    Publication statusPublished - Mar 16 2016

    Fingerprint

    Computer Systems
    Luciferases
    Apoptosis
    Caspase 3
    Neoplasms
    Genes
    Cell Proliferation
    Therapeutics

    All Science Journal Classification (ASJC) codes

    • Molecular Medicine
    • Molecular Biology
    • Genetics

    Cite this

    Kagiya, G., Ogawa, R., Hyodo, F., Yamashita, K., Nakamura, M., Ishii, A., ... Hatashita, M. (2016). Development of a real-time imaging system for hypoxic cell apoptosis. Molecular Therapy - Methods and Clinical Development, 3. https://doi.org/10.1038/mtm.2016.9

    Development of a real-time imaging system for hypoxic cell apoptosis. / Kagiya, Go; Ogawa, Ryohei; Hyodo, Fuminori; Yamashita, Kei; Nakamura, Mizuki; Ishii, Ayumi; Sejimo, Yukihiko; Tominaga, Shintaro; Murata, Masaharu; Tanaka, Yoshikazu; Hatashita, Masanori.

    In: Molecular Therapy - Methods and Clinical Development, Vol. 3, 16.03.2016.

    Research output: Contribution to journalArticle

    Kagiya, G, Ogawa, R, Hyodo, F, Yamashita, K, Nakamura, M, Ishii, A, Sejimo, Y, Tominaga, S, Murata, M, Tanaka, Y & Hatashita, M 2016, 'Development of a real-time imaging system for hypoxic cell apoptosis', Molecular Therapy - Methods and Clinical Development, vol. 3. https://doi.org/10.1038/mtm.2016.9
    Kagiya, Go ; Ogawa, Ryohei ; Hyodo, Fuminori ; Yamashita, Kei ; Nakamura, Mizuki ; Ishii, Ayumi ; Sejimo, Yukihiko ; Tominaga, Shintaro ; Murata, Masaharu ; Tanaka, Yoshikazu ; Hatashita, Masanori. / Development of a real-time imaging system for hypoxic cell apoptosis. In: Molecular Therapy - Methods and Clinical Development. 2016 ; Vol. 3.
    @article{a04e89951dd149ecb7f53a3cab37d0ab,
    title = "Development of a real-time imaging system for hypoxic cell apoptosis",
    abstract = "Hypoxic regions within the tumor form due to imbalances between cell proliferation and angiogenesis; specifically, temporary closure or a reduced flow due to abnormal vasculature. They create environments where cancer cells acquire resistance to therapies. Therefore, the development of therapeutic approaches targeting the hypoxic cells is one of the most crucial challenges for cancer regression. Screening potential candidates for effective diagnostic modalities even under a hypoxic environment would be an important first step. In this study, we describe the development of a real-time imaging system to monitor hypoxic cell apoptosis for such screening. The imaging system is composed of a cyclic luciferase (luc) gene under the control of an improved hypoxic-responsive promoter. The cyclic luc gene product works as a caspase-3 (cas-3) monitor as it gains luc activity in response to cas-3 activation. The promoter composed of six hypoxic responsible elements and the CMV IE1 core promoter drives the effective expression of the cyclic luc gene in hypoxic conditions, enhancing hypoxic cell apoptosis visualization. We also confirmed real-time imaging of hypoxic cell apoptosis in the spheroid, which shares properties with the tumor. Thus, this constructed system could be a powerful tool for the development of effective anticancer diagnostic modalities.",
    author = "Go Kagiya and Ryohei Ogawa and Fuminori Hyodo and Kei Yamashita and Mizuki Nakamura and Ayumi Ishii and Yukihiko Sejimo and Shintaro Tominaga and Masaharu Murata and Yoshikazu Tanaka and Masanori Hatashita",
    year = "2016",
    month = "3",
    day = "16",
    doi = "10.1038/mtm.2016.9",
    language = "English",
    volume = "3",
    journal = "Molecular Therapy - Methods and Clinical Development",
    issn = "2329-0501",
    publisher = "Nature Publishing Group",

    }

    TY - JOUR

    T1 - Development of a real-time imaging system for hypoxic cell apoptosis

    AU - Kagiya, Go

    AU - Ogawa, Ryohei

    AU - Hyodo, Fuminori

    AU - Yamashita, Kei

    AU - Nakamura, Mizuki

    AU - Ishii, Ayumi

    AU - Sejimo, Yukihiko

    AU - Tominaga, Shintaro

    AU - Murata, Masaharu

    AU - Tanaka, Yoshikazu

    AU - Hatashita, Masanori

    PY - 2016/3/16

    Y1 - 2016/3/16

    N2 - Hypoxic regions within the tumor form due to imbalances between cell proliferation and angiogenesis; specifically, temporary closure or a reduced flow due to abnormal vasculature. They create environments where cancer cells acquire resistance to therapies. Therefore, the development of therapeutic approaches targeting the hypoxic cells is one of the most crucial challenges for cancer regression. Screening potential candidates for effective diagnostic modalities even under a hypoxic environment would be an important first step. In this study, we describe the development of a real-time imaging system to monitor hypoxic cell apoptosis for such screening. The imaging system is composed of a cyclic luciferase (luc) gene under the control of an improved hypoxic-responsive promoter. The cyclic luc gene product works as a caspase-3 (cas-3) monitor as it gains luc activity in response to cas-3 activation. The promoter composed of six hypoxic responsible elements and the CMV IE1 core promoter drives the effective expression of the cyclic luc gene in hypoxic conditions, enhancing hypoxic cell apoptosis visualization. We also confirmed real-time imaging of hypoxic cell apoptosis in the spheroid, which shares properties with the tumor. Thus, this constructed system could be a powerful tool for the development of effective anticancer diagnostic modalities.

    AB - Hypoxic regions within the tumor form due to imbalances between cell proliferation and angiogenesis; specifically, temporary closure or a reduced flow due to abnormal vasculature. They create environments where cancer cells acquire resistance to therapies. Therefore, the development of therapeutic approaches targeting the hypoxic cells is one of the most crucial challenges for cancer regression. Screening potential candidates for effective diagnostic modalities even under a hypoxic environment would be an important first step. In this study, we describe the development of a real-time imaging system to monitor hypoxic cell apoptosis for such screening. The imaging system is composed of a cyclic luciferase (luc) gene under the control of an improved hypoxic-responsive promoter. The cyclic luc gene product works as a caspase-3 (cas-3) monitor as it gains luc activity in response to cas-3 activation. The promoter composed of six hypoxic responsible elements and the CMV IE1 core promoter drives the effective expression of the cyclic luc gene in hypoxic conditions, enhancing hypoxic cell apoptosis visualization. We also confirmed real-time imaging of hypoxic cell apoptosis in the spheroid, which shares properties with the tumor. Thus, this constructed system could be a powerful tool for the development of effective anticancer diagnostic modalities.

    UR - http://www.scopus.com/inward/record.url?scp=85015251822&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85015251822&partnerID=8YFLogxK

    U2 - 10.1038/mtm.2016.9

    DO - 10.1038/mtm.2016.9

    M3 - Article

    AN - SCOPUS:85015251822

    VL - 3

    JO - Molecular Therapy - Methods and Clinical Development

    JF - Molecular Therapy - Methods and Clinical Development

    SN - 2329-0501

    ER -